MetaShape Pharma Presents New Data on MS 001 in Combination with GLP-1 Receptor Agonists at ADA 2026 Scientific Sessions
RIEHEN, BASEL, SWITZERLAND, June 9, 2026 /EINPresswire.com/ -- MetaShape Pharma AG (“MetaShape” or the “Company”), a biopharmaceutical company developing MS 001, a first-in-class oral small-molecule drug designed to amplify GLP-1 therapies, today …